These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

158 related articles for article (PubMed ID: 6768154)

  • 21. [Detection of serum fibrinogen degradation products using Merskey's technic, Apropos of 169 cases].
    Kolodié L; Seigneurin D; Micouin C; Hollard D
    Pathol Biol (Paris); 1974 Nov; 22 suppl():66-71. PubMed ID: 4219980
    [No Abstract]   [Full Text] [Related]  

  • 22. Fibrinogen derivatives. A laboratory and clinical study.
    Vermylen J
    Verh K Vlaam Acad Geneeskd Belg; 1972; 34(2):125-208. PubMed ID: 4278099
    [No Abstract]   [Full Text] [Related]  

  • 23. Detection of hypercoagulable states with protamine sulphate tests.
    Lipinski B
    Acta Univ Carol Med Monogr; 1972; 52():185-8. PubMed ID: 4273929
    [No Abstract]   [Full Text] [Related]  

  • 24. Soluble fibrin and fibrinogen-derived material in the kidneys during low-graded disseminated intravascular coagulation (DIC) in rabbits.
    Slaastad RA; Husby G; Skjörten F
    Scand J Haematol; 1974; 13(2):152-9. PubMed ID: 4607676
    [No Abstract]   [Full Text] [Related]  

  • 25. The effect of intravascular and extravascular coagulation on serum fibrin degradation products in rats.
    Vanstone JC; Khoury NY
    Thromb Diath Haemorrh; 1971; 25(1):142-6. PubMed ID: 4996073
    [No Abstract]   [Full Text] [Related]  

  • 26. Molecular composition and biological properties of soluble fibrin polymers encountered in thrombotic states.
    Bang NU; Hansen MS; Smith GF; Latallo ZS; Chang ML; Mattler LE
    Ser Haematol; 1973; 6(4):494-512. PubMed ID: 4277578
    [No Abstract]   [Full Text] [Related]  

  • 27. Determination of soluble fibrin monomer complexes by adsorption on immobilized fibrinogen.
    Stemberger AW; Hörmann H
    Thromb Haemost; 1978 Jun; 39(3):574-81. PubMed ID: 568324
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Occurrence of Soluble Very High Molecular Weight Fibrinogen Complexes in Hypercoagulable States. An in vitro and in vivo Study on their Features.
    Serneri GGE; Gensini GF; Abbate R; Favilla S
    Thromb Haemost; 1979 Jul; 42(1):1561-1573. PubMed ID: 30781910
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Activation of the coagulation cascade in patients with leptospirosis.
    Chierakul W; Tientadakul P; Suputtamongkol Y; Wuthiekanun V; Phimda K; Limpaiboon R; Opartkiattikul N; White NJ; Peacock SJ; Day NP
    Clin Infect Dis; 2008 Jan; 46(2):254-60. PubMed ID: 18171258
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The structure of the fibrinogen degradation products.
    Marder VJ; Budzynski AZ
    Prog Hemost Thromb; 1974; 2(0):141-74. PubMed ID: 4137300
    [No Abstract]   [Full Text] [Related]  

  • 31. Fibrinogen-fibrin-related antigen pattern in human blood. Differences between plasma and serum from pateints with disseminated intravascular coagulation.
    Jacobsen CD; Hoak JC; Wu KK; Fry GL
    Thromb Diath Haemorrh; 1974 Dec; 32(2-3):266-76. PubMed ID: 4217475
    [No Abstract]   [Full Text] [Related]  

  • 32. Rocket immunoelectrophoresis for the rapid quantitation of plasma fibrinogen.
    Saoji AM; Jad CY; Kelkar SS
    Indian J Pathol Microbiol; 1984 Jan; 27(1):1-5. PubMed ID: 6511021
    [No Abstract]   [Full Text] [Related]  

  • 33. [Determination of fibrinogen disintegration in the central retinal vein thrombosis and some other visual conditions].
    Maciejasz A; Grzadzielska E
    Klin Oczna; 1976; 46(12):1415-9. PubMed ID: 1011672
    [No Abstract]   [Full Text] [Related]  

  • 34. The monoclonal antibody that recognizes an epitope in the C-terminal region of the fibrinogen alpha-chain reacts with soluble fibrin and fibrin monomer generated by thrombin but not with those formed as plasmin degradation products.
    Suzuki A; Ebinuma H; Matsuo M; Miyazaki O; Yago H
    Thromb Res; 2007; 121(3):377-85. PubMed ID: 17561232
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Fibrinogen and its derivatives in intravascular coagulation. A review.
    Gerrits WB
    Neth J Med; 1975; 18(1):31-44. PubMed ID: 124019
    [No Abstract]   [Full Text] [Related]  

  • 36. Delayed lung lesion in dogs after thrombin-induced disseminated intravascular coagulation.
    Josephson S; Swedenborg J; Dahlgren SE
    Acta Chir Scand; 1974; 140(6):431-5. PubMed ID: 4428917
    [No Abstract]   [Full Text] [Related]  

  • 37. [Fluctuation of plasma levels of fibrinogen degradation products, fibrin degradation products and total fibrin/fibrinogen degradation products in patients with DIC].
    Isogai N; Kuroso K; Fujimaki M; Yorifuji H; Fukutake K
    Rinsho Byori; 1993 Dec; 41(12):1349-52. PubMed ID: 8295346
    [TBL] [Abstract][Full Text] [Related]  

  • 38. A simple rapid method for isolating soluble fibrin complexes from fibrinogen by treatment with thrombin and t-AMCHA.
    Hayashi S; Yamada K
    Thromb Haemost; 1980 Feb; 42(5):1388-97. PubMed ID: 6154323
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [The detection of preventive hypofibronectinemia in diagnosing the development of disseminated intravascular coagulation in patients with myocardial infarction at the hospital rehabilitation stage].
    Solov'ev AV; Ermolin GA; Soroka VR
    Ter Arkh; 1993; 65(9):22-4. PubMed ID: 8303587
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The coagulation and fibrinolytic responses of baboons after in vivo thrombin generation--effect of interleukin 6.
    Kruithof EK; Mestries JC; Gascon MP; Ythier A
    Thromb Haemost; 1997 May; 77(5):905-10. PubMed ID: 9184401
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.